NCT00498316
- Conditions
- Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +13 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,003 public trials
2,033 recruiting studies
Immunoproliferative Disorders trial results
NCT02168101
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Colorado Blood Cancer Institute Denver, Colorado, United States
- Oncology Hematology Care Cincinnati, Ohio, United States
- Tennessee Oncology PLLC Nashville, Tennessee, United States
- Texas Transplant Institute San Antonio, Texas, United States
Completed
A Study of Different Doses of Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)
NCT02801578
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
NCT01788189
- Conditions
- B-cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- Klinik für Hämatologie, Universitätsklinikum Essen Essen, Germany
NCT00918723
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +22 more
- Locations
-
- Swedish Cancer Institute-Breast Center at First Hill Campus Seattle, Washington, United States
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
NCT01564251
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
- Locations
-
- Yale Cancer Center New Haven, Connecticut, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Karmanos Cancer Institute Detroit, Michigan, United States
- University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States
NCT01678352
- Conditions
- Glioma, Hemic and Lymphatic Diseases, High Risk WHO Grade II Glioma, +15 more
- Locations
-
- University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
NCT01752426
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
NCT02603445
- Conditions
- Follicular Lymphoma, Mantle Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Novartis Investigative Site New York, United States
- Novartis Investigative Site Houston, Texas, United States
- Novartis Investigative Site Salzburg, Austria
- Novartis Investigative Site Pierre-Bénite, France
NCT00294632
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States